UY25069A1 - Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina - Google Patents

Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina

Info

Publication number
UY25069A1
UY25069A1 UY25069A UY25069A UY25069A1 UY 25069 A1 UY25069 A1 UY 25069A1 UY 25069 A UY25069 A UY 25069A UY 25069 A UY25069 A UY 25069A UY 25069 A1 UY25069 A1 UY 25069A1
Authority
UY
Uruguay
Prior art keywords
maleic acid
acid addition
addition salt
tetrahydropyridine
ethyl
Prior art date
Application number
UY25069A
Other languages
English (en)
Spanish (es)
Inventor
Bech Sommer Michael
Ole Nielsen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of UY25069A1 publication Critical patent/UY25069A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY25069A 1997-07-01 1998-06-29 Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina UY25069A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
UY25069A1 true UY25069A1 (es) 1998-12-21

Family

ID=8097489

Family Applications (2)

Application Number Title Priority Date Filing Date
UY25069A UY25069A1 (es) 1997-07-01 1998-06-29 Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina
UY25177A UY25177A1 (es) 1997-07-01 1998-09-10 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY25177A UY25177A1 (es) 1997-07-01 1998-09-10 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina

Country Status (25)

Country Link
EP (1) EP0994869A1 (fr)
JP (1) JP2002507215A (fr)
KR (1) KR20010014297A (fr)
CN (1) CN1261361A (fr)
AR (1) AR013096A1 (fr)
AU (1) AU735751B2 (fr)
BG (1) BG103933A (fr)
BR (1) BR9810331A (fr)
CA (1) CA2293324A1 (fr)
CO (1) CO4940483A1 (fr)
EA (1) EA200000081A1 (fr)
HU (1) HUP0002876A2 (fr)
IL (1) IL133093A0 (fr)
IS (1) IS5278A (fr)
JO (1) JO2031B1 (fr)
MA (1) MA25138A1 (fr)
NO (1) NO996580L (fr)
PE (1) PE116099A1 (fr)
PL (1) PL337184A1 (fr)
SK (1) SK187399A3 (fr)
TN (1) TNSN98120A1 (fr)
TR (1) TR199903283T2 (fr)
UY (2) UY25069A1 (fr)
WO (1) WO1999001448A1 (fr)
ZA (1) ZA985498B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
CA2234824A1 (fr) * 1995-11-06 1997-05-15 Brian R. Pike Traitement de lesions traumatiques du cerveau

Also Published As

Publication number Publication date
KR20010014297A (ko) 2001-02-26
CN1261361A (zh) 2000-07-26
AR013096A1 (es) 2000-12-13
IL133093A0 (en) 2001-03-19
JO2031B1 (en) 1999-05-15
PL337184A1 (en) 2000-08-14
JP2002507215A (ja) 2002-03-05
UY25177A1 (es) 2000-12-29
EP0994869A1 (fr) 2000-04-26
AU8102098A (en) 1999-01-25
MA25138A1 (fr) 2001-04-02
PE116099A1 (es) 1999-11-23
TNSN98120A1 (fr) 2005-03-15
IS5278A (is) 1999-11-30
ZA985498B (en) 1999-01-20
EA200000081A1 (ru) 2000-08-28
BG103933A (en) 2000-07-31
NO996580D0 (no) 1999-12-30
CA2293324A1 (fr) 1999-01-14
AU735751B2 (en) 2001-07-12
CO4940483A1 (es) 2000-07-24
WO1999001448A1 (fr) 1999-01-14
TR199903283T2 (xx) 2000-06-21
SK187399A3 (en) 2000-06-12
BR9810331A (pt) 2000-09-05
HUP0002876A2 (hu) 2001-06-28
NO996580L (no) 1999-12-30

Similar Documents

Publication Publication Date Title
DE69823994T2 (de) 8-azabicyclo(3,2,1)oct-2-en- und octanderivate als liganden der nicotinergen ach rezeptoren
ES2334998T3 (es) Derivado de 2-oxo-1-pirrolidina y sus usos farmaceuticos.
DE69631141T2 (de) Biologisch aktive peptide und ihre zubereitungen und verwendungen
MA20322A1 (fr) Nouveaux derives de n-(4-piperidinyl)-bicyclo condenses 2-imidozolamine et procede pour leur preparation
DE69819891T2 (de) Spiro chinuclidin-derivate, ihre herstellung und verwendung
DE60309740T2 (de) 1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zu ihrer herstellung und therapeutical verwendung
HUT61981A (en) Process for producing unsaturated hydroxyalkylquinoline acids and pharmaceutical compositions comprising same as active ingredient
IT1229203B (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
IL163985A0 (en) Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulation
CN101951766A (zh) 凋亡抑制蛋白抑制剂
CN102458116A (zh) Iap抑制剂
ES2068955T3 (es) Derivados de 1,2,3,4-tetrahidro-9-acridinamina.
FI903835A0 (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiourea och deras derivat.
KR20010014316A (ko) 8-클로로-6,11-디하이드로-11-(4-피페리딜리덴)-5Ｈ-벤조[5,6]사이클로헵타[1,2-ｂ]피리딘의 동질이상체
UY25069A1 (es) Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina
FI900365A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi
EP1651645B1 (fr) N-biarylamides
DE19818964A1 (de) Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
EP1670766B1 (fr) Derivés d'iminoacides bicycliques pour le traitement (entre autres) d'affections de l'appareil locomoteur
FI891155A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
IT8922595A1 (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
WO2003053956A1 (fr) Piperidine-2,6-diones substituees, sur heterocycle, en position 3
JPS58118549A (ja) Ｎ−アシルペプチド、それらの製造法およびそれらの医薬組成物

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121204